Cost effectiveness analyses have been carried out in Sweden

BMJ 1996; 313 doi: 10.1136/bmj.313.7066.1203b (Published 9 November 1996)
Cite this as: BMJ 1996;313:1203.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Lars H Lindholm,
  2. Lars Werko
  1. Chairman of project committee Chairman of board of Swedish Council on Technology Assessment in Health Care Department of Community Health Sciences, Lund University, S-223 54 Lund, Sweden
  2. The report may be requested (free) from the Swedish Council on Technology Assessment in Health Care, PO Box 161 58, S-103 24 Stockholm, Sweden (fax +46 8 611 79 73).

    EDITOR,—T P Fahey and T J Peters applied five different sets of guidelines for the treatment of hypertension to patients from several general practices; only about one third of hypertensive patients met all the guideline criteria.1 In an editorial Rodney T Jackson and David L Sackett suggest (i) that the guidelines overemphasise clinically inappropriate relative measures of the benefit of treating raised blood pressure and (ii) that more interest should be focused on the absolute benefits of antihypertensive treatment.2 They …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL